Retrieve available abstracts of 32 articles: HTML format
Single Articles
September 2025
NIERENGARTEN MB Neoadjuvant immunochemotherapy for nonsurgical HPV-negative head and neck cancer.
Cancer. 2025;131:e70036. PubMed
August 2025
BAI M, Lu Y, Shen L, Yin X, et al Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with
advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b
clinical trial.
Cancer. 2025;131:e70046. PubMedAbstract available
July 2025
NIERENGARTEN MB Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer.
Cancer. 2025;131:e35924. PubMed
HAUGEN CANGE H, Hogmo A, Sandstrom K, Wennerberg J, et al Radiotherapy or surgical treatment of early glottic carcinoma: A population-based
study from the Swedish Head and Neck Cancer Register evaluating primary treatment
outcomes for patients with T1a/T1b tumors.
Cancer. 2025;131:e35955. PubMedAbstract available
April 2025
SAHIN O, Kamel S, Wahid KA, Dede C, et al International multispecialty expert physician preoperative identification of
extranodal extension in patients with oropharyngeal cancer using computed
tomography: Prospective blinded human inter-observer performance evaluation.
Cancer. 2025;131:e35815. PubMedAbstract available
January 2025
KHANNA D, Mishra A, Birur P, Shruti T, et al A prospective study on diagnostic accuracy of technology-enabled early detection
of oral cancer and epidemiology of tobacco and other substances use in rural
India.
Cancer. 2025;131:e35702. PubMedAbstract available
December 2024
NGUYEN T, Koric A, Chang CE, Barul C, et al Coffee and tea consumption and the risk of head and neck cancer: An updated
pooled analysis in the International Head and Neck Cancer Epidemiology
Consortium.
Cancer. 2024 Dec 23. doi: 10.1002/cncr.35620. PubMedAbstract available
NIERENGARTEN MB First person profile: Quynh-Thu Le, MD: Dr Le confronts the difficult challenges
of improving the efficacy and safety of radiation therapy in the treatment of
head and neck cancers.
Cancer. 2024;130:4164. PubMed
ABYANEH R, Ghalehtaki R, Sanford NN Combination of immune checkpoint inhibitors and radiotherapy in locally advanced
esophagogastric junction adenocarcinoma: A review.
Cancer. 2024;130:4040-4051. PubMedAbstract available
NIERENGARTEN MB Promising long-term disease control and survival with pembrolizumab and
cabozantinib for head and neck cancer.
Cancer. 2024;130:3947. PubMed
NIERENGARTEN MB Increased head and neck cancer linked to cannabis use.
Cancer. 2024;130:3946. PubMed
November 2024
DAY AT, Mitchell DN, Eary RL, Jones E, et al Considerations in screening for asymptomatic carotid artery stenosis in
irradiated head and neck cancer survivors.
Cancer. 2024 Nov 26. doi: 10.1002/cncr.35639. PubMed
BERZENJI D, Oude Booijink ORG, Gahrmann R, Mast H, et al A comprehensive approach to defining the cutoff value of oligometastasis in head
and neck squamous cell carcinoma.
Cancer. 2024 Nov 5. doi: 10.1002/cncr.35632. PubMedAbstract available
August 2024
WU Q, Hu C, Feng L, Yang X, et al Comprehensive genomic profiling of infiltrative follicular variant of papillary
thyroid carcinoma.
Cancer. 2024 Aug 14. doi: 10.1002/cncr.35517. PubMedAbstract available
July 2024
SALZ T, Meza AM, Bradshaw PT, Jinna S, et al Role of primary care in opioid prescribing for older head and neck cancer
survivors.
Cancer. 2024 Jul 27. doi: 10.1002/cncr.35478. PubMedAbstract available
GOODMAN KA, Hotca A, Liu M, Strong VE, et al Top advances of the year: Gastroesophageal cancer.
Cancer. 2024;130:2253-2256. PubMed
June 2024
NIERENGARTEN MB First person profile: Everett Vokes, MD: Pioneer of the combination of radiation
and chemotherapy as the first line of treatment for head and neck cancer.
Cancer. 2024;130:2082-2083. PubMed
NIERENGARTEN MB FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
Cancer. 2024;130:1903. PubMed
May 2024
NING T, Li D, Deng T, Bai Y, et al Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor
AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and
esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
Cancer. 2024 May 23. doi: 10.1002/cncr.35377. PubMedAbstract available
NIERENGARTEN MB First person profile: Barbara Burtness, MD: For more than 20 years, she has
applied advances in molecular biology to better treat patients with head and neck
cancers.
Cancer. 2024;130:1724. PubMed
March 2024
CONTRERA KJ, Patel MR, Burtness B, Mehra R, et al The role of surgery and deescalation for HPV-related oropharyngeal cancer.
Cancer. 2024 Mar 18. doi: 10.1002/cncr.35287. PubMedAbstract available
HO AL, Foster NR, Deraje Vasudeva S, Katabi N, et al A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma
(Alliance A091104).
Cancer. 2024;130:702-712. PubMedAbstract available
February 2024
CHOI H, Cho SW, Kim HH, Yi KH, et al Shortened telomere length in peripheral blood leukocytes is associated with
cumulative radioactive iodine doses in patients with differentiated thyroid
carcinoma.
Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256. PubMedAbstract available
DE ALMEIDA JR, Su JS, Kolarski MM, Truong T, et al Development and validation of a novel TNM staging N-classification of oral cavity
squamous cell carcinoma.
Cancer. 2024;130:410-420. PubMedAbstract available
January 2024
GROSS ND, Seiwert TY Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell
carcinoma. Is it time to challenge the standard-of-care?
Cancer. 2024 Jan 18. doi: 10.1002/cncr.35198. PubMed
NIERENGARTEN MB Oral health linked to survival in head and neck cancer.
Cancer. 2024;130:171. PubMed
December 2023
Researchers identify two new subtypes of HPV-associated head and neck cancers.
Cancer. 2023;129:3842. PubMed
October 2023
CARPENTER DJ, Patel P, Niedzwiecki D, Dillon M, et al Long-term risk of carotid stenosis and cerebrovascular disease after radiation
therapy for head and neck cancer.
Cancer. 2023 Oct 28. doi: 10.1002/cncr.35089. PubMedAbstract available
MORAND GB, Eskander A, Fu R, de Almeida J, et al The protective role of postoperative radiation therapy in low and intermediate
grade major salivary gland malignancies: A study of the Canadian Head and Neck
Collaborative Research Initiative.
Cancer. 2023;129:3263-3274. PubMedAbstract available
PHILIPS R, Alnemri A, Amin D, Patel J, et al Effect of preoperative programmed death-1 or programmed death ligand-1 immune
check point inhibition on complications after surgery for primary head and neck
cancer.
Cancer. 2023 Oct 3. doi: 10.1002/cncr.35045. PubMedAbstract available
September 2023
ZHANG L, San Valentin EMD, John TM, Jenq RR, et al Influence of oral microbiome on longitudinal patterns of oral mucositis severity
in patients with squamous cell carcinoma of the head and neck.
Cancer. 2023 Sep 8. doi: 10.1002/cncr.35001. PubMedAbstract available